Brief: Update On Clinical Milestone - CytoMed Therapeutics
20/11/2024 12:15
Nov 20 (Reuters) - CytoMed Therapeutics Ltd F98.F :
* UPDATE ON CLINICAL MILESTONE - CYTOMED THERAPEUTICS
ANNOUNCES
FIRST PATIENT DOSED IN ITS FIRST-IN-HUMAN PHASE I CLINICAL TRIAL
OF ALLOGENEIC CAR-GAMMA DELTA T CELL THERAPY IN PATIENTS WITH
ADVANCED SOLID TUMOURS OR HAEMATOLOGICAL MALIGNANCIES
Source text: ID:nGNX9dJN5l
Further company coverage: F98.F
((Reuters.Briefs@thomsonreuters.com;))
Recent news on CytoMed Therapeutics
See all newsBrief: Cytomed Therapeutics Limited Announces Receipt Of Nasdaq Notification Regarding Minimum Bid Price Deficiency
Brief: Cytomed Therapeutics Refutes "Misleading" Claims & Reaffirms Clinical Progress
Brief: Cytomed Therapeutics Completes Acquisition Of T Cell Technology From Uk To Treat Cancers In China And India
Brief: CytoMed Therapeutics To Start Dose Level 2 In Angelica Trial Q3 2025
Brief: Cytomed Therapeutics Ltd Files For Mixed Shelf Of Up To $50 Million